These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
277 related items for PubMed ID: 28296056
1. Potential of bisbenzimidazole-analogs toward metronidazole-resistant Trichomonas vaginalis isolates. Korosh T, Bujans E, Morada M, Karaalioglu C, Vanden Eynde JJ, Mayence A, Huang TL, Yarlett N. Chem Biol Drug Des; 2017 Oct; 90(4):489-495. PubMed ID: 28296056 [Abstract] [Full Text] [Related]
2. [Investigation of in vitro metronidazole resistance in the clinical isolates of Trichomonas vaginalis]. Ertabaklar H, Yaman Karadam S, Malatyalı E, Ertuğ S. Mikrobiyol Bul; 2016 Oct; 50(4):552-558. PubMed ID: 28124960 [Abstract] [Full Text] [Related]
3. The effect of iron on metronidazole activity against Trichomonas vaginalis in vitro. Elwakil HS, Tawfik RA, Alam-Eldin YH, Nassar DA. Exp Parasitol; 2017 Nov; 182():34-36. PubMed ID: 28935536 [Abstract] [Full Text] [Related]
4. High rates of double-stranded RNA viruses and Mycoplasma hominis in Trichomonas vaginalis clinical isolates in South Brazil. da Luz Becker D, dos Santos O, Frasson AP, de Vargas Rigo G, Macedo AJ, Tasca T. Infect Genet Evol; 2015 Aug; 34():181-7. PubMed ID: 26160539 [Abstract] [Full Text] [Related]
5. The genetic diversity of metronidazole susceptibility in Trichomonas vaginalis clinical isolates in an Egyptian population. Abdel-Magied AA, El-Kholya EI, Abou El-Khair SM, Abdelmegeed ES, Hamoudaa MM, Mohamed SA, El-Tantawy NL. Parasitol Res; 2017 Nov; 116(11):3125-3130. PubMed ID: 28956167 [Abstract] [Full Text] [Related]
6. In vitro susceptibility of Trichomonas vaginalis to metronidazole and treatment outcome in vaginal trichomoniasis. Müller M, Lossick JG, Gorrell TE. Sex Transm Dis; 1988 Nov; 15(1):17-24. PubMed ID: 3258675 [Abstract] [Full Text] [Related]
11. Use of Trichomonas vaginalis clinical isolates to evaluate correlation of gene expression and metronidazole resistance. Mead JR, Fernadez M, Romagnoli PA, Secor WE. J Parasitol; 2006 Feb; 92(1):196-9. PubMed ID: 16629339 [Abstract] [Full Text] [Related]
12. Trichomonas vaginalis prevalence, incidence, risk factors and antibiotic-resistance in an adolescent population. Krashin JW, Koumans EH, Bradshaw-Sydnor AC, Braxton JR, Evan Secor W, Sawyer MK, Markowitz LE. Sex Transm Dis; 2010 Jul; 37(7):440-4. PubMed ID: 20351623 [Abstract] [Full Text] [Related]
13. Drug repositioning for novel antitrichomonas from known antiprotozoan drugs using hierarchical screening. Meneses-Marcel A, Marrero-Ponce Y, Ibáñez-Escribano A, Gómez-Barrio A, Escario JA, Barigye SJ, Terán E, García-Jacas CR, Machado-Tugores Y, Nogal-Ruiz JJ, Arán-Redó VJ. Future Med Chem; 2018 Apr 01; 10(8):863-878. PubMed ID: 29589477 [Abstract] [Full Text] [Related]
15. Three metronidazole-resistant strains of Trichomonas vaginalis from the United States. Müller M, Meingassner JG, Miller WA, Ledger WJ. Am J Obstet Gynecol; 1980 Dec 01; 138(7 Pt 1):808-12. PubMed ID: 7004190 [Abstract] [Full Text] [Related]